Biotech Experiences Strong Open Following Major Announcement
10 Julio 2024 - 9:35AM
AllPennyStocks.com
An Australian biotech company is already
turning heads so far on Wednesday after it was announced results
from its GBM-AGILE, which is a phase II/III study that included
an...
To read the full story on AllPennyStocks.com, click
here.
Kazia Therapeutics (NASDAQ:KZIA)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Kazia Therapeutics (NASDAQ:KZIA)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024